⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Merck to Complete Acquisition of Cidara Therapeutics
businesswire.com
MRK
CDTX
Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3
businesswire.com
MRK
TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Report 2026-2030: Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnology Advance Deep Oncology Pipelines
globenewswire.com
GILD
MRK
ARCX
CGEN
VIR
Industry Veteran Jonathan Freeman, Ph.D. Joins ARTBIO As Chief Business Officer
prnewswire.com
MRK
BAX
Marquis Who's Who Honors Marina Derosa as a Leader in Business Management
accessnewswire.com
JNJ
MRK
BP
Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference
businesswire.com
MRK
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC USA - English APAC - English APAC -
prnewswire.com
MRK
Sterility Testing Market to Reach US$ 3,913.35 Million by 2035 Amid Rising Global Clinical Trial Activity Says Astute Analytica
globenewswire.com
CRL
AMGN
MRK
JNJ
STEM
PCI
NCLH
BioInvent Reports Promising Data from Ongoing Phase 2a study for BI-1808 with KEYTRUDA(R) (pembrolizumab) in Recurrent Ovarian Cancer
accessnewswire.com
MRK
3 Day Pharma Mini MBA Training Course (Mar 18th - Mar 20th, 2026) - ResearchAndMarkets.com
businesswire.com
PFE
MRK
JNJ
GSK